|
Volumn 61, Issue 21, 2001, Pages 7709-7712
|
A proapoptotic peptide for the treatment of solid tumors
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PEPTIDE DP1;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER IMMUNOTHERAPY;
CANCER RADIOTHERAPY;
CELL LINE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG MECHANISM;
HUMAN;
HUMAN CELL;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
SOLID TUMOR;
TUMOR VOLUME;
AMINO ACID SEQUENCE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CASPASE 3;
CASPASES;
CELL CYCLE PROTEINS;
CELL SURVIVAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME ACTIVATION;
FIBROSARCOMA;
HEAD AND NECK NEOPLASMS;
HUMANS;
MICE;
MICE, INBRED C57BL;
MOLECULAR SEQUENCE DATA;
TRANSCRIPTION FACTOR DP1;
TRANSCRIPTION FACTORS;
|
EID: 0035503496
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (239)
|
References (12)
|